Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma

Jatakanon, Anon; Kharitonov, Sergei; Lim, Sam; Barnes, Peter J.
February 1999
Thorax;Feb1999, p108
Academic Journal
No abstract available.


Related Articles

  • Combined budesonide and formoterol for maintenance and relief provided better asthma control than budesonide for maintenance and terbutaline for relief. Rabe, K. F.; Pizzichini, E.; Ställberg, B. // Evidence Based Medicine;Oct2006, Vol. 11 Issue 5, p138 

    The article presents a study on the effectiveness of the combination of budesonide and formoterol in treating patients with mild to moderate asthma. The result showed that budesonide and formoterol in a single inhaler was more effective than a higher dose of budesonide for maintenance plus...

  • Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Kharitonov, S. A.; Donnelly, L. E.; Montuschi, P.; Corradi, M.; Collins, J. V.; Barnes, P. J. // Thorax;Oct2002, Vol. 57 Issue 10, p889 

    Background: Dose dependent anti-inflammatory effects of inhaled corticosteroids in asthma are difficult to demonstrate in clinical practice. The anti-inflammatory effect of low dose inhaled budesonide on non-invasive exhaled markers of inflammation and oxidative stress were assessed in patients...

  • Budesonide/Formoterol: A Review of its Use in Asthma. Goldsmith, David R.; Keating, Gillian M. // Drugs;2004, Vol. 64 Issue 14, p1597 

    Budesonide and formoterol have been combined in a single dry powder device, Symbicort® Turbuhaler® (budesonide/formoterol 160/9–640/18 µg/day), in an effort to simplify asthma management. The efficacy of budesonide/formoterol as maintenance therapy in patients with asthma has...

  • ERRATUM.  // Drugs in R&D;2012, Vol. 12 Issue 1, p15 

    A correction to the article "The effect of budesonide/formoterol pressurized metered-dose inhaler on predefined criteria for worsening asthma in four different patient populations with asthma" is presented.

  • Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Tattersfield, A. E.; Town, G. I.; Johnell, O.; Picado, C.; Aubier, M.; Braillon, P.; Karlström, R. // Thorax;Apr2001, Vol. 56 Issue 4, p272 

    Background--Inhaled corticosteroids are clearly beneficial for patients with asthma of moderate severity, but the risks and benefits of using them in patients with milder asthma are less clear. We have compared the change in bone mineral density over 2 years in adults with mild asthma randomised...

  • Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: Effects on eosinophilic airway inflammation. Takeyama, Kiyoshi; Kondo, Mitsuko; Tagaya, Etsuko; Kirishi, Saori; Ishii, Masanobu; Ochiai, Katsunori; Isono, Kazuo; Tamaoki, Jun // Allergy & Asthma Proceedings;Mar/Apr2014, Vol. 35 Issue 2, p141 

    Although the budesonide and formoterol in a single inhaler for maintenance and reliever therapy has been evaluated in recent studies, the effects on eosinophilic airway inflammation remain uncertain. The purpose of this study was to compare the efficacy, including anti-inflammatory effects, of...

  • Categorizing Asthma Severity:An Overview of National Guidelines. Colice, Gene L. // Clinical Medicine & Research;Aug2004, Vol. 2 Issue 3, p155 

    Asthma is an inflammatory disease of the airways associated with intermittent episodes of bronchospasm. Corticosteroids are the most effective anti-inflammatory class of medication currently available for the treatment of asthma. However, as higher doses of inhaled corticosteroids are used the...

  • Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. Aalbers, René; Boorsma, Martin; van der Woude, Hanneke J.; Jonkers, René E. // Respiratory Research;2010, Vol. 11, p66 

    Background: The budesonide/formoterol combination is successfully used for fast relief of asthma symptoms in addition to its use as maintenance therapy. The temporarily increased corticosteroid dose during increasing inhaler use for symptom relief is likely to suppress any temporary increase in...

  • Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma. Pauwels, Romain A.; Löfdahl, Claes-Göran; Postma, Dirkje S.; Tattersfield, Anne E.; O'Byrne, Paul; Barnes, Peter J.; Ullman, Anders // New England Journal of Medicine;11/13/97, Vol. 337 Issue 20, p1405 

    Background: The role of long-acting, inhaled β2-agonists in treating asthma is uncertain. In a double-blind study, we evaluated the effects of adding inhaled formoterol to both lower and higher doses of the inhaled glucocorticoid budesonide. Methods: After a four-week run-in period of...

  • MicroRNA Expression Profiling in Mild Asthmatic Human Airways and Effect of Corticosteroid Therapy. Williams, Andrew E.; Larner-Svensson, Hanna; Perry, Mark M.; Campbell, Gaynor A.; Herrick, Sarah E.; Adcock, Ian M.; Erjefalt, Jonas S.; Kian Fan Chung; Lindsay, Mark A. // PLoS ONE;2009, Vol. 4 Issue 6, p1 

    Background: Asthma is a common disease characterised by reversible airflow obstruction, bronchial hyperresponsiveness and chronic inflammation, which is commonly treated using corticosteroids such as budesonide. MicroRNAs (miRNAs) are a recently identified family of non-protein encoding genes...


Read the Article


Sign out of this library

Other Topics